Amazon.com Launches Program for GLP-1 Weight-Loss Drugs
Digest more
President Donald Trump once promised lower prices on blockbuster weight-loss drugs in exchange for expanding access through Medicare. Now, that plan is on hold. The Trump administration has indefinitely delayed a proposed Medicare pilot program that would have covered popular GLP-1 drugs like Zepbound and Wegovy,
Trump team delays pilot program for Medicare to cover cost of ‘fat shot’ - Without insurance or discounts, GLP-1 injectables can cost more than $1,000 per month